31results about How to "Easy self-management" patented technology

The various embodiments of the present invention relate to a human identical flowable hormone composition dispersed in a cream or gel contained in the novel “Smart” metered dose applicator, which facilitates numerous patient specific dosing options, dose titration, as well as continuous and variable dosing. The composition is designed for transdermal usage for consumers who follow a specified dosage protocol resulting in static and cyclic variations on serum hormone levels over a 28 day cycle stretched over the span of a month. The regimen is modeled after nature, in an attempt to replicate temporal variations in serum progesterone and estradiol hormone levels of premenopausal females with healthy hormone cycles. A dispenser is also disclosed for flowable cream-base medicaments, specifically; a unidirectional rotatable platform attached to a screw that is slipped into a barrel where it is secured in place and it joins the said components that house an elevator.

The invention discloses a continuous blood sugar monitoring based method for processing and displaying diabetes management information with intervention information. The method comprises an information processing step and an information displaying step. In the information processing step, blood sugar change information is continuously acquired in all weather through an optical monitoring based noninvasive blood sugar monitoring technology; and in the information displaying step, a blood sugar monitoring result generated by continuous blood sugar monitoring is mapped to a two-dimensional graph to be displayed, and a curve graph of blood sugar changed with time change is formed. The method has the beneficial effects that the optical monitoring based noninvasive blood sugar monitoring technology is adopted, and a displaying method for correlating life intervention information of drug treatment, diet, exercise and the like with blood sugar change is provided, so that patients are helped to understand positive effects of the drugs, the exercise and the diet on the blood sugar change, visual knowledge is provided for the patients, and the patients are promoted to actively perform intervention and management.

The invention discloses a monitoring and feedback system for self-management compliance of a diabetic patient. The monitoring and feedback system comprises a patient management module, a self-management knowledge base, a plan management module, a biochemical index management module, a data analysis management module, a group-sending short message module, an information display communication module, a manager module and a printing module. By means of a server platform, a GSM-SM (Global System for Mobile Communications-Short Message) modem and remote control, a network platform is provided, data input by the patient can be received, an analysis chart and an encouraging diagram text are formed and fed back to the patient, and a certain information also can be stored for the patient to inquire. Medical personnel of a hospital can carry out tracking survey and evaluation on the current management situation, carry out statistical analysis on a tracking result and carry out targeted intervention; the monitoring and feedback system not only can be used for scientific research data study on an intervention effect, but also can effectively improve the self-management ability of the patient.

The invention discloses an information push method based on a mobile terminal and a server and a system thereof. The information push method includes that the server receives user physical sign data that are monitored by a wearable device and uploaded by the mobile terminal; historical data of the mobile terminal are obtained, and the historical data include search historical data and access record; matched recommended information is determined according to the historical data of the mobile terminal and the user physical sign data; the recommended information is sent to the mobile terminal. By means of the scheme, personalized service can be provided according to user actual conditions and personal preference so that self management of a user can be facilitated, and conveniences are brought to daily life of the user.

The invention discloses a teaching management system based on a cloud platform. The system comprises a base layer which is used for providing hardware support and data support for the integral teaching management system and providing resource service for a user paid according to demands and comprises an infrastructure layer and a basic service layer, a platform service layer used for providing platform service for the integral teaching management system, and an education application layer used for providing application management for the integral teaching management system, and a structural mode of the teaching management system is an MVC design mode based on SOA configuration.

The invention provides a method of treating a psychiatric or medical disorder in a mammalian subject, the method comprising administering to the subject an effective amount of an oxytocin receptor agonist (e.g., oxytocin). Optionally, the oxytocin receptor agonist is delivered by intranasal administration. Further provided is a method of increasing social cognition, increasing social functioning, increasing empathy, increasing trust of others, reducing paranoia and / or reducing hostility in a subject with a psychotic disorder, a mood disorder characterized by psychotic features, a personality disorder or a pervasive developmental disorder, the method comprising administering to the subject an effective amount of an oxytocin receptor agonist. The invention also contemplates a method of preventing opioid dependence, opioid tolerance and / or opioid withdrawal symptoms in a subject receiving opioid treatment for pain relief, the method comprising administering to the subject an effective amount of an oxytocin receptor agonist. The invention also provides pharmaceutical compositions comprising an effective amount of an oxytocin receptor agonist and a pharmaceutically acceptable carrier.

The modified human PP peptides (i) [Lys4,Leu17,Ser30,Gln34]hPP, (ii) Lys4,Leu17,Thr30,Gln34]hPP; and (iii) [Lys4,Leu17,oxidised Met30,Gln34]hPP wherein “oxidised Met” may be the sulfoxide or sulfone, and certain analogues and derivativatised forms thereof as referred to in the specification, are selective agonists of the Y2 receptor relative to the Y1 and Y4 receptors, and are useful for, for example, appetite control and therapeutic angiogenesis.

The present invention provides a device to facilitate the self-administration of eye drops. The device includes a body portion adapted for placement on the user's face, generally over the eye in which the drops are to be applied. The body portion preferably includes an integral handle which may be held between the thumb and forefinger of the user. Many embodiments may also incorporate a nose bridge to assist in locating the device in the correct position.

There is provided a composition suitable for oral transmucosal administration (sublingual) comprising dexmedetomidine. The composition is useful for the treatment of sleep disorders such as insomnia and capable of providing sleep on demand. The composition comprises an effective amount of dexmedetomidine or pharmaceutically acceptable salts thereof, solvates thereof, or derivatives thereof, formulated for delivery of dexmedetomidine across a subject's oral mucosa.

The Electrical Heat and Vibrating Device is a lightweight, portable, completely self-contained low voltage, and self-administered therapeutic apparatus. More particularly, this invention gives the wearer or user comforting sensations to facilitate a temporary reduction in joint stiffness, joint pain, and joint discomfort, within the human body.

A therapeutic silicone composition and a delivery device operable for the self-administration of the therapeutic silicone composition to the skin. Silicone gel compositions are known in the art to promote wound healing and reduce scarring. The therapeutic silicone composition of the present invention contains a silicone gel formulated with inert thickening agents and / or carriers sufficient to provide a firm, semisolid silicone gel material that substantially retains its shape when extruded from a tube. When topically applied to hypertrophic tissue, the composition, which is applied as a light film to cover the tissue, is transparent and substantially dry, obviating the need for an occlusive dressing.

The invention discloses an intelligent classification management method and system for inspection reports. An inspection report information acquisition module, an inspection report automatic error correction module, an inspection report intelligent discrimination module, an inspection report time classification module, an inspection report storage module and an inspection report display module aredesigned, so a user can input the inspection report result of the traditional paper or other equipment into the system, and the system can arrange and intelligently interpret the collected inspectionreport information, classify and store the inspection report information according to the inspection content category or the time information, and finally perform classification retrieval and resultdisplay according to the user demand. According to the embodiment of the invention, the paper reports can be effectively sorted and stored, so that the user can conveniently classify and consult the examination results, the self-management can be better carried out, and meanwhile, the doctor-patient communication can be enhanced.

The invention discloses a cinema screen advertisement full-automatic delivery system and method. The putting system comprises a user side, a cinema side, an advertisement operation management platform, a cinema management system, a settlement platform and a projector server, wherein the user side is respectively connected with the cinema side and the advertisement operation management platform, the advertisement operation management platform is respectively connected with the cinema management system and the settlement platform, and the cinema management system is connected with the projectorserver. By adopting the delivery system and method provided by the invention, full-process automatic advertisement delivery is realized, a traditional advertisement delivery mode is changed, an advertisement transmission mode of mails and mails is eliminated, online transmission is changed, and quickness and cheapness are realized; advertisement scheduling is automatically generated, advertisements are automatically played according to the scheduling in a cinema, manual operation is not needed, manpower resources are saved, and the occurrence rate of delivery accidents is reduced.

The invention provides a cancer pain treatment management system, which relates to the technical field of medical instruments, and comprises a patient basic information module, a patient grouping information module, a pain evaluation module, a treatment monitoring module, a hospital leaving education and follow-up visit module and a treatment management log module. The system intelligently marks cancer pain patients according to patient information to realize quick grouping; medical staff perform online evaluation on the patient every day to generate a pain curve; the system generates pain medical advice suggestions according to the pain curves, the pain medical advice suggestions are submitted to doctors online after being audited by pharmacists, and the doctors can select acceptance or rejection to obtain pain relieving schemes. After the patient leaves the hospital, the system periodically pushes a follow-up visit table to the patient leaving the hospital and gives medication guidance according to the filled follow-up visit table. According to the system, the functions of automatic screening and marking of pain patients, online pain assessment, intelligent pushing of medical advices for pain, online communication, regular and automatic pushing of out-of-hospital follow-up visit tables, storage and retrieval of past treatment files and the like can be achieved at the same time, a large amount of time can be saved for medical workers, and the working efficiency is improved.

The present invention discloses a transdermal delivery based pharmaceutical composition. The composition comprises a compound as shown in a formula (I) or pharmaceutically acceptable salt thereof, a macromolecular dispersing carrier material, a hot melting protecting agent and an optional fluxing agent. A preparation method of the transdermal delivery based pharmaceutical composition comprises thesteps of micronizing the compound as shown in the formula (I) or the pharmaceutically acceptable salt thereof, the macromolecular dispersing carrier material and the hot melting protecting agent, optionally adding the fluxing agent, mixing the components uniformly, and performing hot melting extrusion and micronizing to obtain microparticles of the compound as shown in the formula (I) or the pharmaceutically acceptable salt thereof. In addition, the invention provides an application of the pharmaceutical composition. The transdermal delivery based pharmaceutical composition can enable the compound as shown in the formula (I) to be quickly absorbed, so that the purpose of calming before anesthesia is achieved, breathing is not affected, and the adverse psychological effects on children dueto intramuscular injection or intravenous injection are avoided. Meanwhile, the pharmaceutical composition also can be used for preventing and / or treating hyperactivity.

An assay test kit is used in a mouth rinse sample collection procedure involving collecting a mouth rinse sample from a patient. A neutrophil reactant diagnostic reagent is delivered to the rinse sample immediately after collection. Diagnostic reagents containing diammonium salts that are reactive with neutrophil enzymes are added to the sample to produce visually discernable colour change in the solution after a selected period of time. Most preferably, the reagents are selected to produce a colour change after a period of time. The reaction is then measured by comparing the resulting sample colour change by eye or mechanically to a standardized colour chart / swatch that correlates with predetermined neutrophil concentrations and / or periodontal disease levels.

The invention provides a wearable continuous blood glucose detection device and method; the device comprises a three-electrode microneedle module, a current-voltage conversion circuit and an MCU module, wherein a three-electrode microneedle penetrates into a corium layer to be in contact with tissue fluid but not in contact with blood; an original current signal is acquired; the acquired original current signal is amplified and filtered and then is processed by the current-voltage conversion circuit and the MCU module to obtain a processed current signal; the processed current signal is converted into the blood glucose concentration according to the relation between the current and the blood glucose concentration; and the blood glucose concentration is sent to an intelligent terminal through a Bluetooth signal. According to the wearable continuous blood glucose detection device and method provided by the invention, the cost is low; and accurate measurement and long-term monitoring of the blood glucose of a patient can be achieved.

Methods and systems are provided for dynamic, self-swarming smart tags. In one example, a system includes a plurality of smart tags each configured to be coupled to a respective component of a medical imaging system. Each smart tag of the plurality of smart tags is configured to broadcast identification information usable by other smart tags in order to dynamically form a family, the family formed based on the broadcast identification information matching stored identification information and further based on a proximity of each smart tag of the plurality of smart tags to one another.

The invention discloses a pharmaceutical composition for transdermal administration. The pharmaceutical composition contains tapentadol or a pharmaceutically acceptable salt thereof, a polymer dispersion carrier material, a hot-melt protective agent and an optional solubilizer. A preparation method of the pharmaceutical composition includes the following steps: mixing the tapentadol or the pharmaceutically acceptable salt thereof, the polymer dispersion carrier material, the hot-melt protective agent and the optional solubilizer, performing hot-melt extrusion, and performing micronization to obtain the microparticles of the tapentadol or the pharmaceutically acceptable salt thereof. The pharmaceutical composition for the transdermal administration can make the tapentadol or the pharmaceutically acceptable salt thereof rapidly absorbed, and achieve the purpose of sedation before anesthesia without affecting breathing, thereby avoiding the adverse psychological effects of intramuscular injection or intravenous injection acupuncture on children; and at the same time, the pharmaceutical composition can also be used to prevent and / or treat and delay the development of Parkinson disease.

The invention discloses a pharmaceutical composition for transdermal administration. The pharmaceutical composition comprises sufentanil or a pharmaceutically acceptable salt thereof, a polymer dispersion carrier material, a hot-melt protective agent and an optional solubilizer. The pharmaceutical composition for transdermal administration is obtained by the following steps: mixing the sufentanilor the pharmaceutically acceptable salt thereof, the polymer dispersion carrier material, the hot-melt protective agent and the optional solubilizer, performing hot-melt extrusion and micronization toobtain microparticles of the sufentanil or the pharmaceutically acceptable salt of the sufentanil. In addition, the invention provides a preparation method and application of the above pharmaceuticalcomposition. According to the pharmaceutical composition for transdermal administration, the sufentanil can be quickly absorbed, the purpose of treating postoperative pain without affecting breathingcan be achieved, and adverse psychological effects of intramuscular injection or intravenous injection acupuncture on patients can be avoided; and at the same time, the pharmaceutical composition canbe used to prevent and / or treat postherpetic neuralgia.

The invention provides an alfentanil pharmaceutical composition for transdermal administration as well as a preparation method and application of the pharmaceutical composition. The pharmaceutical composition for transdermal administration disclosed by the invention comprises alfentanil or a pharmaceutically acceptable salt thereof, a polymer dispersion carrier material, a hot-melt protective agent and an optional solubilizer, the pharmaceutical composition is obtained by the steps of mixing the alfentanil or the pharmaceutically acceptable salt thereof, the polymer dispersion carrier material, the hot-melt protective agent and the optional solubilizer, and performing hot-melt extrusion and micronization to obtain microparticles of the alfentanil or the pharmaceutically acceptable salt ofthe alfentanil. In addition, the invention provides the preparation method and application of the above pharmaceutical composition. According to the pharmaceutical composition for transdermal administration, the alfentanil or the pharmaceutically acceptable salt thereof can be quickly absorbed to achieve the purpose of pain anesthesia in treating without affecting breathing, and avoids the adversepsychological effects brought to patients by intramuscular injection or intravenous injection; and at the same time, the pharmaceutical composition can also be used to prevent and / or treat skin itching.

An assay test kit is used in a mouth rinse sample collection procedure involving collecting a mouth rinse sample from a patient. A neutrophil reactant diagnostic reagent is delivered to the rinse sample immediately after collection. Diagnostic reagents containing diammonium salts that are reactive with neutrophil enzymes are added to the sample to produce visually discernable color change in the solution after a selected period of time. Most preferably, the reagents are selected to produce a color change after a period of time. The reaction is then measured by comparing the resulting sample color change by eye or mechanically to a standardized color chart / swatch that correlates with predetermined neutrophil concentrations and / or periodontal disease levels.

The invention provides a work value cognition system and method; the method comprises the following steps: using a voice identification technology to obtain a work value buying tender of an evaluated person; parsing the work value buying tender so as to obtain the work value evaluation result; sending corresponding prompt information if the work value evaluation result is matched with recruiting information hit or received by the evaluated person. The method and system can automatically remind a job hunting evaluation takers, thus allowing the evaluation takes to self-manage the job hunting process, and reducing job hunting blindness.

The invention discloses a pharmaceutical composition for transdermal administration. The pharmaceutical composition comprises morphin-6-glucuronid or a pharmaceutically acceptable salt thereof, a polymer disperse carrier material, a hot melt protecting agent and an optional fluxing agent, wherein the pharmaceutical composition for transdermal administration is prepared by mixing the morphin-6-glucuronid or the pharmaceutically acceptable salt thereof, the polymer disperse carrier material, the hot melt protecting agent and the optional fluxing agent, and then carrying out hot melt extrusion and micronization to obtain particles of the morphin-6-glucuronid or the pharmaceutically acceptable salt thereof. In addition, the invention further provides a preparation method and application of thepharmaceutical composition. According to the pharmaceutical composition for transdermal administration, the morphin-6-glucuronid or the pharmaceutically acceptable salt thereof can be quickly absorbed to achieve the target of postoperative analgesia without affecting breathing, so that an adverse psychological effect to a patient caused by acupuncture of intramuscular injection or intravenous acupuncture is avoided; and meanwhile, the pharmaceutical composition can also be used for preventing and / or treating lumbar and cervical diseases of the patient.

A pill storage device includes a pill storage casing. The pill storage device casing defines a compartment, and the compartment includes a compartment interior. The compartment interior includes a visual token. The visual token is detectable by a scanning sensor to indicate that contents have been removed from the compartment interior.

The invention provides an externally-used disposable bleeding and fluid effusion stopping device. The device comprises a semi-circular bottom, a cylindrical cylinder with two open ends, a one-way valve and a wide edge containing adhesive, wherein the semi-circular bottom is a special section; the lower end of the cylinder is connected with an opening of the semi-circular bottom; the upper opening of the cylinder is connected with the wide edge; the one-way valve is arranged on one side of the cylinder. According to the device, growth of blood capillaries is promoted through formation of a local hypoxic state, and the content of oxygen in a part of a wound is increased. Natural physical pulling force is applied to the edge of the wound under negative pressure, can promote fissiparity of fibroblast and accelerates epidermis creeping. Besides, maceration of tissue surrounding the wound is unlikely to be caused due to the fact that effusion is removed through a sucking pipe in time, the number of times for dressing is reduced, and convenience is brought for patients and medical workers. The device is reasonable in design, simple to manufacture and low in cost.

The invention discloses a benzodiazepine compound topical pharmaceutical composition. The composition comprises a benzodiazepine compound represented by a formula (I) shown in the specification or a pharmaceutically acceptable salt thereof, a polymer dispersion carrier material, a hot-melt protective agent and an optional solubilizer, the definitions of R1 and R2 in the formula (I) are detailed inthe specification, and the topical pharmaceutical composition is administered transdermally and externally; and a preparation method of the topical pharmaceutical composition includes the steps of micronizing the benzodiazepine compound, the polymer dispersion carrier material and the hot-melt protective agent, optionally adding the solubilizer, performing uniform mixing to obtain a physical mixture, performing hot-melt extrusion, and performing micronization to obtain the benzodiazepine compound particles. The invention also provides an application of the above pharmaceutical composition. The pharmaceutical composition can be used for calming the heart and tranquilizing and allaying excitement, and realizing hypnosis, and improves sleep quality, people is clear-headed after using the pharmaceutical composition, the compound represented by the formula (I) has no residues or accumulation in vivo, does not affect work in a next day, and makes the user full of spirit and energy.

The invention discloses a hospital-community-family three-in-one chronic disease health management system. The system comprises physical examination equipment and a cloud platform connected to the physical examination equipment. The cloud platform is connected with a patient terminal, a hospital terminal and a community terminal. Databases of all patients are stored in the cloud platform; the patient terminal is bound with a corresponding patient and is used for accessing a database of the corresponding patient; the community terminal is bound with a plurality of corresponding patient terminals and is used for accessing the databases of bound patients; the hospital terminal is bound to a plurality of patient terminals and is used for accessing the databases of the bound patients; the physical examination equipment is used for carrying out physical examination on the patient and uploading identity information and a physical examination result of the current physical examination patientto the cloud platform, the cloud platform sends the physical examination result to the corresponding patient terminal and the community terminal according to the identity information of the current patient, and meanwhile database data of the corresponding patient is updated. Physical examination and self-evaluation of the patient can be synchronized to the cloud platform and shared to the community terminal, the patient terminal and the family member terminal, so that joint supervision of family members and follow-up visit tracking by a community health center for the patient can be realized and the health management effect for the patient can be enhanced.

The invention discloses a benzodiazepine compound topical pharmaceutical composition, which comprises a benzodiazepine compound represented by formula (I) or a pharmaceutically acceptable salt thereof, a polymer dispersion carrier material, a thermal melt protector and optionally The fluxing agent, R in formula (I) 1 and R 2 See the description for the definition of , the topical pharmaceutical composition is for skin external use and transdermal administration; the preparation method of the topical composition includes the benzodiazepine compound, polymer dispersion The agent is micronized, a melting agent is optionally added, and mixed uniformly to obtain a physical mixture, which is then hot-melt extruded and micronized to obtain the benzodiazepine compound particles. Uses of the above pharmaceutical composition are also provided. The pharmaceutical composition can be used for calming the mind, sedation, hypnosis, improving sleep quality, clearing the mind after use, the compound represented by the formula (I) has no residue or accumulation in the body, does not affect the work of the next day, and is full of energy.

An intranasal nano autophagy inducer for preventing and treating early neurodegenerative diseases comprises hydrophobic molecules (i.e., hydrophobic small molecules or autophagy inducer) having autophagy inducing effects and amphiphilic surfactant. Firstly configuring a good solvent solution, preparing a suspension emulsion of self-contained nanoparticles without carriers by a reprecipitation method, freeze-drying to prepare a freeze-dried powder, and resuspending the freeze-dried powder in isotonic saline to obtain the intranasal nano autophagy inducer before immediate use.